Nanobiotix S.A. ADR (NBTX)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Laurent Lévy |
| Employees: | 100 |
| Web site: | nanobiotix.com |
|
60 RUE DE WATTIGNIES, PARIS, I0, 75012
33140260470
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Nanobiotix S.A. focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer and non-small cell lung cancer.
Please log in first to see chart